Published : Sep-2020
No. of Pages : 57
1.1 List of Tables
1.2 List of Figures
2 Gastric Cancer: Executive Summary
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors
3.3 Global and Historical Trends
3.3.1 8MM Trends in the Diagnosed Incidence
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods
3.5 Epidemiological Forecast for Gastric Cancer (2019-2029)
3.5.1 Diagnosed Incident Cases of Gastric Cancer
3.5.2 Age-Specific Diagnosed Incident Cases of Gastric Cancer
3.5.3 Sex-Specific Diagnosed Incident Cases of Gastric Cancer
3.5.4 Five-Year Diagnosed Prevalent Cases of Gastric Cancer
3.5.5 Diagnosed Incident Cases of Gastric Cancer by Stage at Diagnosis
3.5.6 Diagnosed Incident Cases of Gastric Cancer with HER-2 Overexpression
3.5.7 Diagnosed Incident Cases of Gastric Cancer with PD-L1 Expression
3.5.8 Diagnosed Incident Cases of Gastric Cancer with MSI
3.5.9 Diagnosed Incident Cases of Gastric Cancer with NTRK Gene Fusions
3.5.10 Diagnosed Incident Cases of GEJ Cancer
3.5.11 Diagnosed Incident Cases of Gastric Cancer, excluding GEJ Cancer
3.5.12 Diagnosed Incident Cases of Gastric Adenocarcinoma
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 COVID-19 Impact
3.6.3 Limitations of Analysis
3.6.4 Strengths of Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About GlobalData
4.4 Contact Us
4.5 Disclaimer
List of Tables
Table 1: Summary of Newly Added Data Types and Countries and Different Segments
Table 2: Summary of Updated Data Types
Table 3: Risk Factors for Gastric Cancer
List of Figures
Figure 1: 8MM, Diagnosed Incident Cases of Gastric Cancer, Men and Women, Ages ?20 Years, 2019 and 2029, N
Figure 2: 8MM, Five-year Diagnosed Prevalent Cases of Gastric Cancer, Men and Women, Ages ?20 Years, 2019 and 2029, N
Figure 3: 8MM, Diagnosed Incidence of Gastric Cancer, Men, Ages ?20 Years, 2009-2029, Cases Per 100,000 Population
Figure 4: 8MM, Diagnosed Incidence of Gastric Cancer, Women, Ages ?20 Years, 2009-2029, Cases Per 100,000 Population
Figure 5: Sources Used and Not Used for Diagnosed Incident Cases of Gastric Cancer
Figure 6: Sources Used for Diagnosed Incident Cases of Gastric Cancer by Stage at Diagnosis
Figure 7: Sources Used for Five-Year Diagnosed Prevalent Cases of Gastric Cancer
Figure 8: Sources Used for Diagnosed Incident Cases of Gastric Cancer with HER-2 Overexpression
Figure 9: Sources Used for Diagnosed Incident Cases of Gastric Cancer with PD-L1 Expression
Figure 10: Sources Used for Diagnosed Incident Cases of Gastric Cancer with MSI
Figure 11: Sources Used for Diagnosed Incident Cases of Gastric Cancer with NTRK Gene Fusions
Figure 12: Sources Used for Diagnosed Incident Cases of GEJ Cancer
Figure 13: Sources Used for Diagnosed Incident Cases of Gastric Cancer, excluding GEJ Cancer
Figure 14: Sources Used for Diagnosed Incident Cases of Gastric Adenocarcinoma
Figure 15: 8MM, Diagnosed Incident Cases of Gastric Cancer, Men and Women, Ages ?20 Years, 2019
Figure 16: 8MM, Age-Specific Diagnosed Incident Cases of Gastric Cancer, Men and Women, Ages ?20 Years, 2019
Figure 17: 8MM, Sex-Specific Diagnosed Incident Cases of Gastric Cancer, Men and Women, Ages ?20 Years, 2019, N
Figure 18: 8MM, Five-Year Diagnosed Prevalent Cases of Gastric Cancer, Men and Women, Ages ?20 Years, 2019
Figure 19: 8MM, Diagnosed Incident Cases of Gastric Cancer by Stage at Diagnosis, Men and Women, Ages ?20 Years, 2019
Figure 20: 8MM, Diagnosed Incident Cases of Gastric Cancer with HER-2 Overexpression, Men and Women, Ages ?20 Years, 2019
Figure 21: 8MM, Diagnosed Incident Cases of Gastric Cancer with PD-L1 Expression, Men and Women, Ages ?20 Years, 2019
Figure 22: 8MM, Diagnosed Incident Cases of Gastric Cancer with MSI, Men and Women, Ages ?20 Years, 2019
Figure 23: 8MM, Diagnosed Incident Cases of Gastric Cancer with NTRK Gene Fusions, Men and Women, Ages ?20 Years, 2019
Figure 24: 8MM, Diagnosed Incident Cases of GEJ Cancer, Men and Women, Ages ?20 Years, 2019
Figure 25: 8MM, Diagnosed Incident Cases of Gastric Cancer, excluding GEJ Cancer, Men and Women, Ages ?20 Years, 2019
Figure 26: 8MM, Diagnosed Incident Cases of Gastric Adenocarcinoma, Men and Women, Ages ?20 Years, 2019
